Sumitomo Mitsui Trust Group Inc. boosted its stake in Colgate-Palmolive (NYSE:CL – Free Report) by 1.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 1,989,776 shares of the company’s stock after buying an additional 23,099 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Colgate-Palmolive were worth $206,559,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Harbour Investments Inc. raised its stake in shares of Colgate-Palmolive by 7.1% in the third quarter. Harbour Investments Inc. now owns 9,836 shares of the company’s stock valued at $1,021,000 after acquiring an additional 650 shares during the last quarter. Entropy Technologies LP bought a new position in Colgate-Palmolive in the 3rd quarter valued at $5,638,000. Apollon Wealth Management LLC boosted its stake in Colgate-Palmolive by 3.9% in the third quarter. Apollon Wealth Management LLC now owns 22,571 shares of the company’s stock worth $2,343,000 after purchasing an additional 839 shares in the last quarter. Nations Financial Group Inc. IA ADV grew its holdings in shares of Colgate-Palmolive by 10.8% during the third quarter. Nations Financial Group Inc. IA ADV now owns 13,320 shares of the company’s stock worth $1,383,000 after purchasing an additional 1,296 shares during the last quarter. Finally, Jag Capital Management LLC increased its stake in shares of Colgate-Palmolive by 2.0% in the third quarter. Jag Capital Management LLC now owns 33,546 shares of the company’s stock valued at $3,482,000 after buying an additional 647 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. TD Cowen reduced their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Barclays boosted their price objective on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price objective for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Morgan Stanley upped their price target on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research note on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average price target of $105.11.
Insider Buying and Selling at Colgate-Palmolive
In related news, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.34% of the company’s stock.
Colgate-Palmolive Trading Down 0.5 %
NYSE CL opened at $91.51 on Wednesday. Colgate-Palmolive has a one year low of $75.17 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The firm has a market cap of $74.76 billion, a P/E ratio of 26.22, a P/E/G ratio of 3.31 and a beta of 0.42. The stock’s 50-day moving average is $100.62 and its 200-day moving average is $98.52.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.19%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Where Do I Find 52-Week Highs and Lows?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- The How And Why of Investing in Oil Stocks
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.